Skip to main content
Clinical Trials/NCT03316053
NCT03316053
Active, not recruiting
Not Applicable

Cell Marker Predictors in Barrett's Esophagus

The Guthrie Clinic1 site in 1 country25 target enrollmentNovember 15, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Barrett's Esophagus Without Dysplasia
Sponsor
The Guthrie Clinic
Enrollment
25
Locations
1
Primary Endpoint
Cell Markers
Status
Active, not recruiting
Last Updated
3 months ago

Overview

Brief Summary

The purpose of this study is to analyze biopsied tissue samples for changes in cells and genes involved in Barrett's Esophagus.

Detailed Description

Patients with a history of Barrett's esophagus who are scheduled for a routine endoscopy will have an additional biopsy taken for genetic testing.

Registry
clinicaltrials.gov
Start Date
November 15, 2017
End Date
December 1, 2027
Last Updated
3 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • History of Barrett's esophagus; scheduled for routine upper endoscopy

Exclusion Criteria

  • Under 18 years of age
  • Unable to consent on own behalf

Outcomes

Primary Outcomes

Cell Markers

Time Frame: through study completion, an average of 1 year

Identify genes involved in Barrett's Esophagus

Study Sites (1)

Loading locations...

Similar Trials